HEADER HYDROLASE/HYDROLASE INHIBITOR 12-FEB-03 1OD1 TITLE ENDOTHIAPEPSIN PD135,040 COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENDOTHIAPEPSIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ASPARTATE PROTEASE, EAPA, EPN-1; COMPND 5 EC: 3.4.23.22 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CRYPHONECTRIA PARASITICA; SOURCE 3 ORGANISM_COMMON: CHESNUT BLIGHT FUNGUS; SOURCE 4 ORGANISM_TAXID: 5116; SOURCE 5 OTHER_DETAILS: ENDOTHIA PARASITICA KEYWDS ACID PROTEINASE, INHIBITOR, ASPARTYL PROTEASE, HYDROLASE-HYDROLASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR L.COATES,P.T.ERSKINE,S.MALL,R.S.GILL,S.P.WOOD,J.B.COOPER REVDAT 3 13-JUL-11 1OD1 1 VERSN REVDAT 2 24-FEB-09 1OD1 1 VERSN REVDAT 1 12-JUN-03 1OD1 0 JRNL AUTH L.COATES,P.T.ERSKINE,S.MALL,P.A.WILLIAMS,R.S.GILL,S.P.WOOD, JRNL AUTH 2 J.B.COOPER JRNL TITL THE STRUCTURE OF ENDOTHIAPEPSIN COMPLEXED WITH THE GEM-DIOL JRNL TITL 2 INHIBITOR PD-135,040 AT 1.37 A JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 59 978 2003 JRNL REFN ISSN 0907-4449 JRNL PMID 12777758 JRNL DOI 10.1107/S0907444903006267 REMARK 2 REMARK 2 RESOLUTION. 1.37 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.37 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : 5% REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.125 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.159 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 3461 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 64650 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : NULL REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.116 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.150 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.300 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 2794 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 52508 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2389 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 64 REMARK 3 SOLVENT ATOMS : 418 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 2905.00 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 2287.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 16 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 26565 REMARK 3 NUMBER OF RESTRAINTS : 32311 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.012 REMARK 3 ANGLE DISTANCES (A) : 0.042 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.029 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.061 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.069 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.051 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.004 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.046 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.085 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: MOEWS & KRETSINGER REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1OD1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-FEB-03. REMARK 100 THE PDBE ID CODE IS EBI-12047. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-JAN-03 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 4.60 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.918056 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 68317 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.370 REMARK 200 RESOLUTION RANGE LOW (A) : 10.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 200 DATA REDUNDANCY : 6.800 REMARK 200 R MERGE (I) : 0.11300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 3.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.37 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.44 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.5 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : 0.36500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.46 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.43 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 4.60 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 36.62450 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 HYDROLYSES PROTEINS WITH BROAD SPECIFICITY LIKE PEPSIN A REMARK 400 PREFERRING HYDROPHOBIC RESIDUES AT P1 AND P1'. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 TYR A 59 CB - CG - CD1 ANGL. DEV. = 3.7 DEGREES REMARK 500 GLN A 140 CA - CB - CG ANGL. DEV. = 14.6 DEGREES REMARK 500 ASP A 160 CB - CG - OD2 ANGL. DEV. = -5.6 DEGREES REMARK 500 ASP A 279 CB - CG - OD1 ANGL. DEV. = 7.4 DEGREES REMARK 500 PHE A 280 CB - CG - CD2 ANGL. DEV. = -4.4 DEGREES REMARK 500 PHE A 280 CB - CG - CD1 ANGL. DEV. = 5.6 DEGREES REMARK 500 PHE A 280 O - C - N ANGL. DEV. = -11.6 DEGREES REMARK 500 SER A 288 O - C - N ANGL. DEV. = -11.5 DEGREES REMARK 500 SER A 289 C - N - CA ANGL. DEV. = 16.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2026 DISTANCE = 7.49 ANGSTROMS REMARK 525 HOH A2071 DISTANCE = 5.64 ANGSTROMS REMARK 525 HOH A2073 DISTANCE = 5.04 ANGSTROMS REMARK 525 HOH A2076 DISTANCE = 6.63 ANGSTROMS REMARK 525 HOH A2114 DISTANCE = 5.31 ANGSTROMS REMARK 525 HOH A2196 DISTANCE = 6.29 ANGSTROMS REMARK 630 REMARK 630 MOLECULE TYPE: NULL REMARK 630 MOLECULE NAME: N~2~-[(2R)-2-BENZYL-3-(TERT-BUTYLSULFONYL) REMARK 630 PROPANOYL]-N-{(1R)-1-(CYCLOHEXYLMETHYL)-3,3-DIFLUORO-2,2-DIHYDROXY REMARK 630 -4-[(2-MORPHOLIN-4-YLETHYL)AMINO]-4-OXOBUTYL}-3-(1H-IMIDAZOL-3-IUM REMARK 630 -4-YL)-L-ALANINAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 0QS A 400 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: TSM PHE HIS CHF EMR REMARK 630 DETAILS: NULL REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0QS A 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1E5O RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEX WITH INHIBITOR DB2 REMARK 900 RELATED ID: 1E80 RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEX WITH RENIN INHIBITOR MERCK-KGAA- REMARK 900 EMD56133 REMARK 900 RELATED ID: 1E81 RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEX WITH RENIN INHIBITOR MERCK-KGAA- REMARK 900 EMD61395 REMARK 900 RELATED ID: 1E82 RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEX WITH RENIN INHIBITOR MERCK-KGAA- REMARK 900 EMD59601 REMARK 900 RELATED ID: 1EED RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEX WITH THE CYCLOHEXYL RENIN INHIBITOR REMARK 900 PD125754 REMARK 900 RELATED ID: 1ENT RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEX WITH THE INHIBITOR PD130328 REMARK 900 RELATED ID: 1EPL RELATED DB: PDB REMARK 900 RELATED ID: 1EPM RELATED DB: PDB REMARK 900 RELATED ID: 1EPN RELATED DB: PDB REMARK 900 RELATED ID: 1EPO RELATED DB: PDB REMARK 900 RELATED ID: 1EPP RELATED DB: PDB REMARK 900 RELATED ID: 1EPQ RELATED DB: PDB REMARK 900 RELATED ID: 1EPR RELATED DB: PDB REMARK 900 RELATED ID: 1ER8 RELATED DB: PDB REMARK 900 RELATED ID: 1GKT RELATED DB: PDB REMARK 900 NEUTRON LAUE DIFFRACTION STRUCTURE OF ENDOTHIAPEPSIN REMARK 900 COMPLEXED WITH TRANSITION STATE ANALOGUE INHIBITOR H261 REMARK 900 RELATED ID: 1GVT RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEX WITH CP-80,794 REMARK 900 RELATED ID: 1GVU RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEX WITH H189 REMARK 900 RELATED ID: 1GVV RELATED DB: PDB REMARK 900 FIVE ATOMIC RESOLUTION STRUCTURES OF ENDOTHIAPEPSIN REMARK 900 INHIBITOR COMPLEXES; IMPLICATIONS FOR THE ASPARTIC REMARK 900 PROTEINASE MECHANISM REMARK 900 RELATED ID: 1GVW RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEX WITH PD-130,328 REMARK 900 RELATED ID: 1GVX RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEXED WITH H256 REMARK 900 RELATED ID: 2ER0 RELATED DB: PDB REMARK 900 RELATED ID: 2ER6 RELATED DB: PDB REMARK 900 RELATED ID: 2ER7 RELATED DB: PDB REMARK 900 RELATED ID: 2ER9 RELATED DB: PDB REMARK 900 RELATED ID: 3ER3 RELATED DB: PDB REMARK 900 RELATED ID: 3ER5 RELATED DB: PDB REMARK 900 RELATED ID: 4APE RELATED DB: PDB REMARK 900 RELATED ID: 4ER1 RELATED DB: PDB REMARK 900 RELATED ID: 4ER2 RELATED DB: PDB REMARK 900 RELATED ID: 4ER4 RELATED DB: PDB REMARK 900 RELATED ID: 5ER1 RELATED DB: PDB REMARK 900 RELATED ID: 5ER2 RELATED DB: PDB DBREF 1OD1 A 1 330 UNP P11838 CARP_CRYPA 90 419 SEQRES 1 A 330 SER THR GLY SER ALA THR THR THR PRO ILE ASP SER LEU SEQRES 2 A 330 ASP ASP ALA TYR ILE THR PRO VAL GLN ILE GLY THR PRO SEQRES 3 A 330 ALA GLN THR LEU ASN LEU ASP PHE ASP THR GLY SER SER SEQRES 4 A 330 ASP LEU TRP VAL PHE SER SER GLU THR THR ALA SER GLU SEQRES 5 A 330 VAL ASP GLY GLN THR ILE TYR THR PRO SER LYS SER THR SEQRES 6 A 330 THR ALA LYS LEU LEU SER GLY ALA THR TRP SER ILE SER SEQRES 7 A 330 TYR GLY ASP GLY SER SER SER SER GLY ASP VAL TYR THR SEQRES 8 A 330 ASP THR VAL SER VAL GLY GLY LEU THR VAL THR GLY GLN SEQRES 9 A 330 ALA VAL GLU SER ALA LYS LYS VAL SER SER SER PHE THR SEQRES 10 A 330 GLU ASP SER THR ILE ASP GLY LEU LEU GLY LEU ALA PHE SEQRES 11 A 330 SER THR LEU ASN THR VAL SER PRO THR GLN GLN LYS THR SEQRES 12 A 330 PHE PHE ASP ASN ALA LYS ALA SER LEU ASP SER PRO VAL SEQRES 13 A 330 PHE THR ALA ASP LEU GLY TYR HIS ALA PRO GLY THR TYR SEQRES 14 A 330 ASN PHE GLY PHE ILE ASP THR THR ALA TYR THR GLY SER SEQRES 15 A 330 ILE THR TYR THR ALA VAL SER THR LYS GLN GLY PHE TRP SEQRES 16 A 330 GLU TRP THR SER THR GLY TYR ALA VAL GLY SER GLY THR SEQRES 17 A 330 PHE LYS SER THR SER ILE ASP GLY ILE ALA ASP THR GLY SEQRES 18 A 330 THR THR LEU LEU TYR LEU PRO ALA THR VAL VAL SER ALA SEQRES 19 A 330 TYR TRP ALA GLN VAL SER GLY ALA LYS SER SER SER SER SEQRES 20 A 330 VAL GLY GLY TYR VAL PHE PRO CYS SER ALA THR LEU PRO SEQRES 21 A 330 SER PHE THR PHE GLY VAL GLY SER ALA ARG ILE VAL ILE SEQRES 22 A 330 PRO GLY ASP TYR ILE ASP PHE GLY PRO ILE SER THR GLY SEQRES 23 A 330 SER SER SER CYS PHE GLY GLY ILE GLN SER SER ALA GLY SEQRES 24 A 330 ILE GLY ILE ASN ILE PHE GLY ASP VAL ALA LEU LYS ALA SEQRES 25 A 330 ALA PHE VAL VAL PHE ASN GLY ALA THR THR PRO THR LEU SEQRES 26 A 330 GLY PHE ALA SER LYS HET 0QS A 400 54 HET SO4 A 500 5 HET SO4 A 501 5 HETNAM 0QS N~2~-[(2R)-2-BENZYL-3-(TERT-BUTYLSULFONYL)PROPANOYL]-N- HETNAM 2 0QS {(1R)-1-(CYCLOHEXYLMETHYL)-3,3-DIFLUORO-2,2-DIHYDROXY- HETNAM 3 0QS 4-[(2-MORPHOLIN-4-YLETHYL)AMINO]-4-OXOBUTYL}-3-(1H- HETNAM 4 0QS IMIDAZOL-3-IUM-4-YL)-L-ALANINAMIDE HETNAM SO4 SULFATE ION HETSYN 0QS PD-135,040 FORMUL 2 0QS C36 H56 F2 N7 O8 S 1+ FORMUL 3 SO4 2(O4 S 2-) FORMUL 5 HOH *418(H2 O) HELIX 1 1 THR A 49 VAL A 53 5 5 HELIX 2 2 THR A 60 SER A 64 5 5 HELIX 3 3 SER A 113 GLU A 118 1 6 HELIX 4 4 PHE A 130 ASN A 134 5 5 HELIX 5 5 THR A 143 LYS A 149 1 7 HELIX 6 6 ALA A 150 LEU A 152 5 3 HELIX 7 7 PRO A 228 ALA A 237 1 10 HELIX 8 8 PRO A 274 TYR A 277 5 4 HELIX 9 9 GLY A 306 LYS A 311 1 6 SHEET 1 AA 3 LYS A 68 SER A 78 0 SHEET 2 AA 3 SER A 84 VAL A 96 -1 O SER A 85 N ILE A 77 SHEET 3 AA 3 TYR A 17 ILE A 23 -1 O GLN A 22 N SER A 95 SHEET 1 AB 7 LYS A 68 SER A 78 0 SHEET 2 AB 7 SER A 84 VAL A 96 -1 O SER A 85 N ILE A 77 SHEET 3 AB 7 LEU A 99 VAL A 112 -1 O LEU A 99 N VAL A 96 SHEET 4 AB 7 LEU A 41 VAL A 43 1 O LEU A 41 N GLU A 107 SHEET 5 AB 7 GLY A 124 GLY A 127 -1 O LEU A 125 N TRP A 42 SHEET 6 AB 7 GLN A 28 ASP A 35 1 O ASP A 33 N LEU A 126 SHEET 7 AB 7 TYR A 17 ILE A 23 -1 O THR A 19 N LEU A 32 SHEET 1 AC 7 ALA A 269 ILE A 273 0 SHEET 2 AC 7 PHE A 262 VAL A 266 -1 O PHE A 262 N ILE A 273 SHEET 3 AC 7 GLU A 196 VAL A 204 -1 N THR A 200 O GLY A 265 SHEET 4 AC 7 LYS A 210 ALA A 218 -1 O LYS A 210 N TYR A 202 SHEET 5 AC 7 ASN A 303 PHE A 305 1 O ASN A 303 N ILE A 217 SHEET 6 AC 7 LEU A 225 LEU A 227 -1 O TYR A 226 N ILE A 304 SHEET 7 AC 7 ILE A 294 SER A 296 1 O GLN A 295 N LEU A 227 SHEET 1 AD 4 LYS A 243 SER A 245 0 SHEET 2 AD 4 GLY A 250 PRO A 254 -1 O GLY A 250 N SER A 245 SHEET 3 AD 4 SER A 289 GLY A 292 -1 O CYS A 290 N PHE A 253 SHEET 4 AD 4 ASP A 279 PRO A 282 -1 N PHE A 280 O PHE A 291 SSBOND 1 CYS A 255 CYS A 290 1555 1555 2.01 CISPEP 1 THR A 25 PRO A 26 0 -8.57 CISPEP 2 SER A 137 PRO A 138 0 2.15 SITE 1 AC1 21 ASP A 15 ASP A 33 ASP A 35 GLY A 37 SITE 2 AC1 21 SER A 38 TYR A 79 GLY A 80 ASP A 81 SITE 3 AC1 21 SER A 83 PHE A 116 ASP A 119 LEU A 133 SITE 4 AC1 21 ASP A 219 GLY A 221 THR A 222 THR A 223 SITE 5 AC1 21 ILE A 304 HOH A2415 HOH A2416 HOH A2417 SITE 6 AC1 21 HOH A2418 SITE 1 AC2 9 GLY A 72 GLY A 181 SER A 182 HOH A2141 SITE 2 AC2 9 HOH A2382 HOH A2408 HOH A2409 HOH A2410 SITE 3 AC2 9 HOH A2411 SITE 1 AC3 8 SER A 213 ILE A 214 ASP A 215 ASN A 303 SITE 2 AC3 8 HOH A2313 HOH A2412 HOH A2413 HOH A2414 CRYST1 53.201 73.249 45.993 90.00 110.10 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018797 0.000000 0.006878 0.00000 SCALE2 0.000000 0.013652 0.000000 0.00000 SCALE3 0.000000 0.000000 0.023152 0.00000